4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Vera Therapeutics, Inc. (VERA) operates in the Biotechnology industry and is headquartered in Brisbane, United States with about 339 employees. Its market capitalization is roughly $3 billion. In the fiscal year ended 2025-12-31, VERA reported $0M in revenue and ($300M) in net income.
Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of transformative treatments for patients with immunological diseases.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($316M) | ($167M) | ($102M) | ($91M) | — |
| Net Income | ($300M) | ($152M) | ($96M) | ($89M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($125M) | ($94M) | ($84M) | ($80M) | ($57M) |
| Net Income | ($121M) | ($91M) | ($80M) | ($76M) | ($52M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $735M | $656M | $176M | $131M | — |
| Total Liabilities | $130M | $78M | $74M | $54M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive VERA viewer.
About TickerBase · Data methodology & sources